You can’t change your genes, but you can change your behavior. You can take steps to prevent disease, lower your risk, or find problems early when treatments work best.
Let's Talk About Whole Genome Sequencing!
Science and technology have advanced at extraordinary rates in the ten years since the completion of the human genome project. The first whole genome sequence was an enormous feat, the work of many great minds spread out over six countries. It took nearly twelve years and $3 billion to complete. Now sequencing a genome takes only a few hours, and the cost has drastically decreased to only a few thousand dollars.
Through the end of the year, the Genes in Life blog will be diving into the exciting world of whole genome sequencing, covering the basics of the history, technology, and what this can mean for health now as well as in the future.
Whole genome sequencing is a controversial topic. This blog strives to report on the facts and to cover both sides of each argument fairly. However, if you feel that any side is being underrepresented, please feel free to jump into the conversation! We would love to hear your feedback through the comments section so long as we can keep the discussion respectful.
Remember too that whole genome sequencing is very complicated. If you have any questions as we go through this spotlight, please ask them to our featured experts on whole genome sequencing on our Ask the Experts page.
Genes in Life is proud and excited to have several sponsors for our spotlight on whole genome sequencing. Visit Our Sponsors page to learn more.
The Illumina Understand Your Genome symposium engages, educates, and motivates the medical and academic community towards a better understanding of our DNA and its implications for healthcare. It’s a movement and it starts, literally, at the DNA level of the participants themselves. Illumina is a proud sponsor of Genes in Life.
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company that is committed to providing the most innovative products and services to leading customers in the fields of scientific research, genetic analysis and applied sciences. With a presence in more than 180 countries, the company's portfolio of 50,000 end-to-end solutions is secured by more than 5,000 patents and licenses that span the entire biological spectrum -- scientific exploration, molecular diagnostics, 21st century forensics, regenerative medicine and agricultural research. Life Technologies has approximately 10,000 employees and had sales of $3.8 billion in 2012.
Claritas Genomics is a clinical genetic diagnostic testing company that combines the clinical expertise of the world's best pediatric specialists with next generation sequencing technology to inform and improve patient care. Claritas offers a full range of services that take the guesswork out of selecting molecular tests and support clinicians as they navigate the increasingly complex landscape of genetic diagnostics. Claritas's interpretive services are based on the most up to date and reliable findings and the Claritas reports are designed to clearly communicate complex genetic information to inform medical treatment. Originally Boston Children's Hospital's clinical molecular testing laboratory, Claritas was launched as an independent laboratory in February 2013.